Summary
Global
Markets Direct's, 'RAC-Gamma Serine/Threonine-Protein Kinase (Akt-3 or Protein
Kinase Akt-3 or Protein Kinase B Gamma or RAC-PK-Gamma or STK-2 or EC 2.7.11.1)
- Pipeline Review, H1 2016', provides in depth analysis on RAC-Gamma
Serine/Threonine-Protein Kinase (Akt-3 or Protein Kinase Akt-3 or Protein
Kinase B Gamma or RAC-PK-Gamma or STK-2 or EC 2.7.11.1) targeted pipeline
therapeutics.
The
report provides comprehensive information on the RAC-Gamma
Serine/Threonine-Protein Kinase (Akt-3 or Protein Kinase Akt-3 or Protein
Kinase B Gamma or RAC-PK-Gamma or STK-2 or EC 2.7.11.1), targeted therapeutics,
complete with analysis by indications, stage of development, mechanism of
action (MoA), route of administration (RoA) and molecule type. The report also
covers the descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved in
RAC-Gamma Serine/Threonine-Protein Kinase (Akt-3 or Protein Kinase Akt-3 or
Protein Kinase B Gamma or RAC-PK-Gamma or STK-2 or EC 2.7.11.1) targeted therapeutics
development and features dormant and discontinued projects.
View Summary of
This Report @ http://www.radiantinsights.com/research/rac-gamma-serine-threonine-protein-kinase
Global
Markets Direct's report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct's proprietary
databases, company/university websites, clinical trial registries, conferences,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources. Drug
profiles featured in the report undergoes periodic review following a stringent
set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure
that the most recent developments are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the market and
their portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.
Buy a Sample Copy of This Report @ http://www.radiantinsights.com/research/rac-gamma-serine-threonine-protein-kinase/request-sample
About Us:
Radiant
Insights Inc. is a platform for companies looking to meet their market research
and business intelligence requirements. We assist and facilitate organizations
and individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
Contact
Details:
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
28
2nd Street,
Suite
3036 San Francisco,
CA
94105 United States
Phone:
1-415-349-0054
Toll
Free: 1-888-202-9519
Website:
http://www.radiantinsights.com/
Email:
sales@radiantinsights.com
No comments:
Post a Comment